• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implementing an earlier and more intensive follow-up in acute heart failure: the STRONG-HF and COACH trials.

作者信息

Rosano Giuseppe M C, Savarese Gianluigi

机构信息

Centre for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy.

Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

出版信息

Nat Rev Cardiol. 2023 Apr;20(4):213-214. doi: 10.1038/s41569-023-00841-x.

DOI:10.1038/s41569-023-00841-x
PMID:36747103
Abstract
摘要

相似文献

1
Implementing an earlier and more intensive follow-up in acute heart failure: the STRONG-HF and COACH trials.
Nat Rev Cardiol. 2023 Apr;20(4):213-214. doi: 10.1038/s41569-023-00841-x.
2
Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet.美国心脏病学会2007年临床试验更新：ALPHA、EVEREST、FUSION II、VALIDD、PARR - 2、REMODEL、SPICE、COURAGE、COACH、REMADHE、用于评估呼吸困难的脑钠肽前体以及THIS饮食。
Eur J Heart Fail. 2007 Jun-Jul;9(6-7):740-5. doi: 10.1016/j.ejheart.2007.04.004. Epub 2007 May 3.
3
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).适度或强化疾病管理计划对心力衰竭患者预后的影响：心力衰竭咨询与辅导结果协调研究（COACH）
Arch Intern Med. 2008 Feb 11;168(3):316-24. doi: 10.1001/archinternmed.2007.83.
4
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.因新发诊断或恶化的慢性心力衰竭住院：来自 ASCEND-HF 试验。
J Am Coll Cardiol. 2017 Jun 27;69(25):3029-3039. doi: 10.1016/j.jacc.2017.04.043.
5
Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1.2009 年美国心力衰竭学会会议上的临床试验更新：FAST、IMPROVE-HF、COACH 半乳糖凝集素-3 亚组研究、HF-ACTION 核亚组研究、DAD-HF 和 MARVEL-1。
Eur J Heart Fail. 2010 Feb;12(2):193-6. doi: 10.1093/eurjhf/hfp185. Epub 2009 Dec 30.
6
Characteristics and outcomes of heart failure-related hospitalization in adults with congenital heart disease.患有先天性心脏病的成人心力衰竭相关住院的特征与结局
Arch Cardiovasc Dis. 2017 May;110(5):283-291. doi: 10.1016/j.acvd.2017.01.008. Epub 2017 Mar 14.
7
Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.心脏再同步治疗的轻度心力衰竭患者临床获益的长期外推：REVERSE 研究 5 年随访分析。
JACC Heart Fail. 2015 Sep;3(9):691-700. doi: 10.1016/j.jchf.2015.05.005. Epub 2015 Aug 12.
8
Rationale and design of a risk-guided strategy for reducing readmissions for acute decompensated heart failure: the Risk-HF study.基于风险的策略降低急性失代偿性心力衰竭再住院率的研究：Risk-HF 研究。
ESC Heart Fail. 2020 Oct;7(5):3151-3160. doi: 10.1002/ehf2.12897. Epub 2020 Jul 22.
9
Predictive Value of the Get With The Guidelines Heart Failure Risk Score in Unselected Cardiac Intensive Care Unit Patients.指南指导下心力衰竭风险评分在未选择的心脏重症监护病房患者中的预测价值。
J Am Heart Assoc. 2020 Feb 4;9(3):e012439. doi: 10.1161/JAHA.119.012439. Epub 2020 Jan 28.
10
Depression and the usefulness of a disease management program in heart failure: insights from the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) study.抑郁和心力衰竭疾病管理计划的有用性：来自 COACH（心力衰竭咨询和辅导效果评估协调研究）研究的见解。
J Am Coll Cardiol. 2010 Apr 27;55(17):1837-43. doi: 10.1016/j.jacc.2009.11.082.

引用本文的文献

1
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes.ARNI在射血分数降低的心力衰竭（HFrEF）伴或不伴心房颤动患者的指南导向药物治疗（GDMT）中的真实世界应用：心脏和肾脏功能及临床结局的回顾性分析
J Cardiovasc Dev Dis. 2025 Aug 26;12(9):328. doi: 10.3390/jcdd12090328.
2
Empowering European hospital pharmacists in the face of heart failure.助力欧洲医院药剂师应对心力衰竭
Eur J Hosp Pharm. 2024 Jun 21;31(4):287-288. doi: 10.1136/ejhpharm-2023-004068.

本文引用的文献

1
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.升阶梯治疗急性心力衰竭指南导向的药物治疗的安全性、耐受性和疗效（STRONG-HF）：一项多中心、开放标签、随机试验。
Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7.
2
Trial of an Intervention to Improve Acute Heart Failure Outcomes.改善急性心力衰竭预后的干预措施试验
N Engl J Med. 2023 Jan 5;388(1):22-32. doi: 10.1056/NEJMoa2211680. Epub 2022 Nov 5.
3
Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF).
心力衰竭药物治疗-惰性、滴定和停药：一项多中心观察性研究（EVOLUTION HF）。
JACC Heart Fail. 2023 Jan;11(1):1-14. doi: 10.1016/j.jchf.2022.08.009. Epub 2022 Sep 7.
4
Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence.心力衰竭和慢性肾脏病患者中指南推荐的药物治疗的使用：从医生的处方到患者的配药、药物依从性和持久性。
Eur J Heart Fail. 2022 Nov;24(11):2185-2195. doi: 10.1002/ejhf.2620. Epub 2022 Aug 2.
5
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):1757-1780. doi: 10.1016/j.jacc.2021.12.011. Epub 2022 Apr 1.
6
Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata.基于证据的治疗在射血分数降低的心力衰竭各年龄段患者中的应用。
Eur J Heart Fail. 2022 Jun;24(6):1047-1062. doi: 10.1002/ejhf.2483. Epub 2022 Apr 3.
7
Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure.心力衰竭患者在专科与初级保健随访中的特征和结局。
ESC Heart Fail. 2022 Apr;9(2):822-833. doi: 10.1002/ehf2.13848. Epub 2022 Feb 15.
8
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
9
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology.心力衰竭患者特征分析以制定个体化的医学治疗方案。欧洲心脏病学会心力衰竭协会的共识文件。
Eur J Heart Fail. 2021 Jun;23(6):872-881. doi: 10.1002/ejhf.2206. Epub 2021 May 20.
10
Nurse-Led Heart Failure Clinics Are Associated With Reduced Mortality but Not Heart Failure Hospitalization.护士主导的心力衰竭诊所与降低死亡率相关，但与心力衰竭住院无关。
J Am Heart Assoc. 2019 May 21;8(10):e011737. doi: 10.1161/JAHA.118.011737.